The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey

Introduction: Favipiravir (FVP) is an antiviral and used to treat COVID-19. We aimed to document the safety and adverse events associated with FVP on the outcome of COVID-19 treatment. Methodology: The study included 225 adult patients with moderate COVID-19 infection (World Health Organization s...

Full description

Bibliographic Details
Published in:Journal of Infection in Developing Countries
Main Authors: Elif Tukenmez Tigen, Buket Erturk Sengel, Beste Ozben, Hande Perk Gurun, Baran Balcan, Beliz Bilgili, Fethi Gul, Zekaver Odabasi, Volkan Korten
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2023-11-01
Subjects:
favipiravir
safety
adverse events
COVID-19
hepatotoxicity
nephrotoxicity
Online Access:https://jidc.org/index.php/journal/article/view/18041

Internet

https://jidc.org/index.php/journal/article/view/18041

Similar Items